Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
Aranda Pharma Overview
Latest Deal Type
Latest Deal Amount
Aranda Pharma General Information
Developer of novel antiandrogen drugs intended to combat prostate cancer and neurodegenerative diseases. The company's drugs are made of small molecules and androgen receptor antagonists that are non-toxic, and provide effective treatments for hair loss and acne, which are underrepresented drug targets despite being validated without affecting hormonal function in other parts of the body, enabling clients to improve the quality of life for millions of people suffering from hair loss and acne.